{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T16:41:53Z","timestamp":1649176913046},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T00:00:00Z","timestamp":1423094400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12883-015-0260-1","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T08:22:57Z","timestamp":1423038177000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Edina","family":"Silajd\u017ei\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bj\u00f6rkqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,5]]},"reference":[{"key":"260_CR1","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/nm1102-1218","volume":"8","author":"CJ Binder","year":"2002","unstructured":"Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, et al. Innate and acquired immunity in atherogenesis. Nat Med. 2002;8:1218\u201326.","journal-title":"Nat Med"},{"key":"260_CR2","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1172\/JCI118288","volume":"96","author":"JM Heery","year":"1995","unstructured":"Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM, et al. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest. 1995;96:2322\u201330.","journal-title":"J Clin Invest"},{"key":"260_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clim.2009.08.013","volume":"134","author":"J Frostegard","year":"2010","unstructured":"Frostegard J. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease. Clin Immunol. 2010;134:47\u201354.","journal-title":"Clin Immunol"},{"key":"260_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/biof.200","volume":"38","author":"JC de la Torre","year":"2012","unstructured":"de la Torre JC. A turning point for Alzheimer\u2019s disease? Biofactors. 2012;38:78\u201383.","journal-title":"Biofactors"},{"key":"260_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1212\/01.wnl.0000341271.90478.8e","volume":"72","author":"A Viswanathan","year":"2009","unstructured":"Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: how to move forward? Neurology. 2009;72:368\u201374.","journal-title":"Neurology"},{"key":"260_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1474-4422(08)70021-8","volume":"7","author":"GJ Biessels","year":"2008","unstructured":"Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008;7:184\u201390.","journal-title":"Lancet Neurol"},{"key":"260_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ana.21009","volume":"60","author":"HC Chui","year":"2006","unstructured":"Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ, et al. Cognitive impact of subcortical vascular and Alzheimer\u2019s disease pathology. Ann Neurol. 2006;60:677\u201387.","journal-title":"Ann Neurol"},{"key":"260_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0140-6736(96)09328-2","volume":"349","author":"A Hofman","year":"1997","unstructured":"Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer\u2019s disease in the Rotterdam Study. Lancet. 1997;349:151\u20134.","journal-title":"Lancet"},{"key":"260_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jns.2012.07.032","volume":"322","author":"RN Kalaria","year":"2012","unstructured":"Kalaria RN, Akinyemi R, Ihara M. Does vascular pathology contribute to Alzheimer changes? J Neurol Sci. 2012;322:141\u20137.","journal-title":"J Neurol Sci"},{"key":"260_CR10","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","volume":"322","author":"M Kivipelto","year":"2001","unstructured":"Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and Alzheimer\u2019s disease in later life: longitudinal, population based study. BMJ. 2001;322:1447\u201351.","journal-title":"BMJ"},{"key":"260_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1212\/01.wnl.0000172914.08967.dc","volume":"65","author":"JA Luchsinger","year":"2005","unstructured":"Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology. 2005;65:545\u201351.","journal-title":"Neurology"},{"key":"260_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/aje\/154.7.635","volume":"154","author":"JA Luchsinger","year":"2001","unstructured":"Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer\u2019s disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001;154:635\u201341.","journal-title":"Am J Epidemiol"},{"key":"260_CR13","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1212\/01.wnl.0000279520.59792.fe","volume":"69","author":"MM Mielke","year":"2007","unstructured":"Mielke MM, Rosenberg PB, Tschanz J, Cook L, Corcoran C, Hayden KM, et al. Vascular factors predict rate of progression in Alzheimer disease. Neurology. 2007;69:1850\u20138.","journal-title":"Neurology"},{"key":"260_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","volume":"347","author":"I Skoog","year":"1996","unstructured":"Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141\u20135.","journal-title":"Lancet"},{"key":"260_CR15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3233\/JAD-2010-091705","volume":"21","author":"UK Eriksson","year":"2010","unstructured":"Eriksson UK, Sjoberg BG, Bennet AM, de Faire U, Pedersen NL, Frostegard J. Low levels of antibodies against phosphorylcholine in Alzheimer\u2019s disease. J Alzheimers Dis. 2010;21:577\u201384.","journal-title":"J Alzheimers Dis"},{"key":"260_CR16","first-page":"567","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-III-R","author":"American Psychiatric Association","year":"1987","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-III-R. Washington, D.C: American Psychiatric Association; 1987. p. 567. xxix."},{"key":"260_CR17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34:939\u201344.","journal-title":"Neurology"},{"key":"260_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"GC Roman","year":"1993","unstructured":"Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies, Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250\u201360.","journal-title":"Neurology"},{"key":"260_CR19","first-page":"23","volume":"59","author":"T Erkinjuntti","year":"2000","unstructured":"Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl. 2000;59:23\u201330.","journal-title":"J Neural Transm Suppl"},{"key":"260_CR20","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1212\/WNL.53.5.902","volume":"53","author":"IG McKeith","year":"1999","unstructured":"McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop: diagnosis and treatment, Consortium on Dementia with Lewy Bodies. Neurology. 1999;53:902\u20135.","journal-title":"Neurology"},{"key":"260_CR21","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1001\/archneur.58.11.1803","volume":"58","author":"GM McKhann","year":"2001","unstructured":"McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick\u2019s Disease. Arch Neurol. 2001;58:1803\u20139.","journal-title":"Arch Neurol"},{"key":"260_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2009.05.003","volume":"34","author":"U de Faire","year":"2010","unstructured":"de Faire U, Su J, Hua X, Frostegard A, Halldin M, Hellenius ML, et al. Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism. J Autoimmun. 2010;34:73\u20139.","journal-title":"J Autoimmun"},{"key":"260_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/STROKEAHA.109.558742","volume":"41","author":"R Fiskesund","year":"2010","unstructured":"Fiskesund R, Stegmayr B, Hallmans G, Vikstrom M, Weinehall L, de Faire U, et al. Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden. Stroke. 2010;41:607\u201312.","journal-title":"Stroke"},{"key":"260_CR24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/HJR.0b013e32832a05df","volume":"16","author":"H Gronlund","year":"2009","unstructured":"Gronlund H, Hallmans G, Jansson JH, Boman K, Wikstrom M, de Faire U, et al. Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden. Eur J Cardiovasc Prev Rehabil. 2009;16:382\u20136.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"260_CR25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.atherosclerosis.2008.07.009","volume":"203","author":"BG Sjoberg","year":"2009","unstructured":"Sjoberg BG, Su J, Dahlbom I, Gronlund H, Wikstrom M, Hedblad B, et al. Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men. Atherosclerosis. 2009;203:528\u201332.","journal-title":"Atherosclerosis"},{"key":"260_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010;6:131\u201344.","journal-title":"Nat Rev Neurol"},{"key":"260_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2004.06.011","volume":"293","author":"ND Padilla","year":"2004","unstructured":"Padilla ND, Ciurana C, van Oers J, Ogilvie AC, Hack CE. Levels of natural IgM antibodies against phosphorylcholine in healthy individuals and in patients undergoing isolated limb perfusion. J Immunol Methods. 2004;293:1\u201311.","journal-title":"J Immunol Methods"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-015-0260-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0260-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0260-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0260-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:47:41Z","timestamp":1630568861000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-015-0260-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,5]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["260"],"URL":"https:\/\/doi.org\/10.1186\/s12883-015-0260-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,5]]},"assertion":[{"value":"29 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"8"}}